Gerald A. Dienel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gerald A. Dienel has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
Nancy F. Cruz
Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
22 shared publications- Douglas L. Rothman
Department of Biomedical Engineering Yale University New Haven Connecticut USA
9 shared publications Kelly K. Ball
8 shared publicationsGautam K. Gandhi
Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, Arkansas
4 shared publicationsKelly K Ball
Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, U.S.A.
3 shared publications- Kevin L. Behar
Department of Psychiatry, Magnetic Resonance Research Center, Yale University School of Medicine, New Haven, Connecticut, USA
3 shared publications
Latest Publications
- 30 August 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
Brain energy metabolism and metabolic water in ageing, Alzheimer’s, and other neurological diseases
Glucose oxidation is the brain’s main way of producing the energy needed for neuronal signaling and essential maintenance tasks. When the brain cannot produce or use energy efficiently, neurons become less functional and more vulnerable. Although ageing is thought to affect brain metabolism, precise measurements of oxidative glucose use are still limited. This review brings together current evidence on how brain energy metabolism changes during healthy ageing, dementia, and major neurological disorders, using absolute measurements of oxygen consumption. Overall, the data show that oxidative glucose metabolism stays stable in healthy brain ageing. In contrast, it drops by up to ~40% in Alzheimer’s disease, more with greater disease severity, and by ~ 25% in multiple sclerosis and hydrocephalus. These declines reduce the amount of ATP available for both signaling and basic cellular functions, which are essential for perception and cognition. Metabolic water production is proportionately reduced when CMR O2 decreases in diseased brain, and its secretion into interstitial fluid is diminished. In disease, lower oxidative metabolic activity reduces metabolic water production, which may in turn affect brain fluid dynamics, including processes involved in neuroprotection and waste clearance.
- 30 August 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
Brain energy metabolism and metabolic water in ageing, Alzheimer’s, and other neurological diseases
Glucose oxidation is the brain’s main way of producing the energy needed for neuronal signaling and essential maintenance tasks. When the brain cannot produce or use energy efficiently, neurons become less functional and more vulnerable. Although ageing is thought to affect brain metabolism, precise measurements of oxidative glucose use are still limited. This review brings together current evidence on how brain energy metabolism changes during healthy ageing, dementia, and major neurological disorders, using absolute measurements of oxygen consumption. Overall, the data show that oxidative glucose metabolism stays stable in healthy brain ageing. In contrast, it drops by up to ~40% in Alzheimer’s disease, more with greater disease severity, and by ~ 25% in multiple sclerosis and hydrocephalus. These declines reduce the amount of ATP available for both signaling and basic cellular functions, which are essential for perception and cognition. Metabolic water production is proportionately reduced when CMR O2 decreases in diseased brain, and its secretion into interstitial fluid is diminished. In disease, lower oxidative metabolic activity reduces metabolic water production, which may in turn affect brain fluid dynamics, including processes involved in neuroprotection and waste clearance.
- Open Access
- 17 April 2026
- Published by Oxford University Press (OUP) in Oxford Open Neuroscience
- Vol. 5
Anesthesia, perimortem conditions, and brain harvest method govern the measured metabolome: analysis of substandard samples generates flawed metabolite levels
Metabolism and energetics are closely integrated with brain function, and understanding how metabolic dysfunction contributes to neurological disease may help improve therapeutic approaches. Characterization of in situ metabolite levels, spatial distributions, and metabolomes requires special attention to anesthesia use, perimortem conditions, and tissue harvest. Anesthesia, CO2 asphyxiation, vascular perfusion, and decapitation alter metabolism, thereby substantially changing the metabolome, lipidome, and neurotransmitter profile. Analysis of flawed samples produces artifactual data, raising concerns about conclusions regarding the cellular basis of metabolism, metabolite shuttling, pathway activities, labeled metabolite profiling and imaging, and relationships between metabolism, function, and neurological disorders. Appropriate procedures for in vivo metabolic assays and tissue harvest are widely-unrecognized but essential components of metabolic and metabolomic studies.
- 17 April 2026
- Published by Oxford University Press (OUP) in Oxford Open Neuroscience
- Vol. 5
Open AccessAnesthesia, perimortem conditions, and brain harvest method govern the measured metabolome: analysis of substandard samples generates flawed metabolite levels
Metabolism and energetics are closely integrated with brain function, and understanding how metabolic dysfunction contributes to neurological disease may help improve therapeutic approaches. Characterization of in situ metabolite levels, spatial distributions, and metabolomes requires special attention to anesthesia use, perimortem conditions, and tissue harvest. Anesthesia, CO2 asphyxiation, vascular perfusion, and decapitation alter metabolism, thereby substantially changing the metabolome, lipidome, and neurotransmitter profile. Analysis of flawed samples produces artifactual data, raising concerns about conclusions regarding the cellular basis of metabolism, metabolite shuttling, pathway activities, labeled metabolite profiling and imaging, and relationships between metabolism, function, and neurological disorders. Appropriate procedures for in vivo metabolic assays and tissue harvest are widely-unrecognized but essential components of metabolic and metabolomic studies.
- Open Access
- 23 October 2025
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 22 (1) , 1-4
Reply to Comment by Quistorff: ATP is not consumed solely by hydrolytic reactions
A Comment to our recent paper that described a budget for brain metabolic water production claimed that all ATP produced by oxidation of glucose is consumed by hydrolysis, and that the net calculated production of metabolic water is equal to that obtained by combustion of glucose. However, ATP is synthesized and consumed by enzymatic reactions that do not involve water in the mechanism. Not all ATP consumed is hydrolyzed.
- 23 October 2025
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 22 (1) , 1-4
Open AccessReply to Comment by Quistorff: ATP is not consumed solely by hydrolytic reactions
A Comment to our recent paper that described a budget for brain metabolic water production claimed that all ATP produced by oxidation of glucose is consumed by hydrolysis, and that the net calculated production of metabolic water is equal to that obtained by combustion of glucose. However, ATP is synthesized and consumed by enzymatic reactions that do not involve water in the mechanism. Not all ATP consumed is hydrolyzed.
- Open Access
- 14 August 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (8) , e70197
Comment on the Editorial “Embracing the Modern Biochemistry of Brain Metabolism”
The editorial “Embracing the Modern Biochemistry of Brain Metabolism” takes exception with some critics who “persist in refuting intercellular metabolic exchange”, singling out our recent review “A bird's‐eye view of glycolytic upregulation in activated brain: The major fate of lactate is release from activated tissue, not shuttling to nearby neurons”. However, it is important to note that our review did not refute intercellular metabolic exchange or shuttles. The review only refuted the concept that most of the incremental neuronal energy needed to support increased signaling during activation is supplied by an astrocyte‐to‐neuron lactate shuttle (ANLS) as originally proposed more than 30 years ago. Like the authors of the editorial, we also advocate for a rigorous research agenda, and we agree that elucidating the intricate and dynamic intercellular metabolic exchanges in brain tissue, beyond merely lactate, is essential to advance clinical and neuroprotective treatments. However, we reject their claim that our review represents “a minority school of thought” that “continues to dispute this concept without offering compelling scientific proof”. The evidence refuting a major role of the ANLS is in our detailed, fact‐based review for interested neuroscientists to read and evaluate for themselves.
- 14 August 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (8) , e70197
Open AccessComment on the Editorial “Embracing the Modern Biochemistry of Brain Metabolism”
The editorial “Embracing the Modern Biochemistry of Brain Metabolism” takes exception with some critics who “persist in refuting intercellular metabolic exchange”, singling out our recent review “A bird's‐eye view of glycolytic upregulation in activated brain: The major fate of lactate is release from activated tissue, not shuttling to nearby neurons”. However, it is important to note that our review did not refute intercellular metabolic exchange or shuttles. The review only refuted the concept that most of the incremental neuronal energy needed to support increased signaling during activation is supplied by an astrocyte‐to‐neuron lactate shuttle (ANLS) as originally proposed more than 30 years ago. Like the authors of the editorial, we also advocate for a rigorous research agenda, and we agree that elucidating the intricate and dynamic intercellular metabolic exchanges in brain tissue, beyond merely lactate, is essential to advance clinical and neuroprotective treatments. However, we reject their claim that our review represents “a minority school of thought” that “continues to dispute this concept without offering compelling scientific proof”. The evidence refuting a major role of the ANLS is in our detailed, fact‐based review for interested neuroscientists to read and evaluate for themselves.
- Open Access
- 6 June 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (6) , e70111
A Bird's‐Eye View of Glycolytic Upregulation in Activated Brain: The Major Fate of Lactate Is Release From Activated Tissue, Not Shuttling to Nearby Neurons
Glucose is the major, obligatory fuel for the brain, and nearly all glucose is oxidized in the awake, resting state. However, during activation, much of the glucose is not oxidized even though adequate oxygen is available, ATP demand is increased, and glycolysis generates less ATP than oxidation. The fate of the lactate produced by glycolysis is a highly debated topic, in part because its origin and fate in the living brain are difficult to measure. One idea has been that astrocytes generate lactate and shuttle it to neurons as a major fuel, but critical elements of the shuttle model are not validated, and there is no compelling evidence to support shuttling coupled with oxidation in vivo. Metabolic brain imaging reveals rapid loss of labeled metabolites of glucose from activated tissue that is mediated by lactate transporters and gap junctional trafficking among astrocytes. Lactate is highly labeled by [13C‐ and 14C]glucose, it is diffusible, and it is quickly released to blood and the perivascular‐lymphatic drainage system. During intense sensory stimulation, astrocytic glycogen is consumed at half the rate of glucose by all brain cells; it is a major fuel. The oxygen‐carbohydrate metabolic mismatch increases when glycogen is included in the calculation, revealing that glycogen is not oxidized. Although the energetics of brain activation is complex, metabolic modeling with comparison to a wide range of experimental data relating metabolism to neurotransmission strongly supports two concepts: (i) glycogenolysis in astrocytes spares blood‐borne glucose for activated neurons, and (ii) the increase in cerebral blood flow in excess of oxygen consumption removes protons produced by glycolytic metabolism to maintain tissue pH, pO2, and pCO2 homeostasis. Several studies have identified processes and situations that involve neuronal aerobic glycolysis, and a better understanding of the roles of glycolysis in neuron‐astrocyte interactions and functional metabolism in the normal and diseased brain is required. image
- 6 June 2025
- Published by Wiley in Journal of Neurochemistry
- Vol. 169 (6) , e70111
Open AccessA Bird's‐Eye View of Glycolytic Upregulation in Activated Brain: The Major Fate of Lactate Is Release From Activated Tissue, Not Shuttling to Nearby Neurons
Glucose is the major, obligatory fuel for the brain, and nearly all glucose is oxidized in the awake, resting state. However, during activation, much of the glucose is not oxidized even though adequate oxygen is available, ATP demand is increased, and glycolysis generates less ATP than oxidation. The fate of the lactate produced by glycolysis is a highly debated topic, in part because its origin and fate in the living brain are difficult to measure. One idea has been that astrocytes generate lactate and shuttle it to neurons as a major fuel, but critical elements of the shuttle model are not validated, and there is no compelling evidence to support shuttling coupled with oxidation in vivo. Metabolic brain imaging reveals rapid loss of labeled metabolites of glucose from activated tissue that is mediated by lactate transporters and gap junctional trafficking among astrocytes. Lactate is highly labeled by [13C‐ and 14C]glucose, it is diffusible, and it is quickly released to blood and the perivascular‐lymphatic drainage system. During intense sensory stimulation, astrocytic glycogen is consumed at half the rate of glucose by all brain cells; it is a major fuel. The oxygen‐carbohydrate metabolic mismatch increases when glycogen is included in the calculation, revealing that glycogen is not oxidized. Although the energetics of brain activation is complex, metabolic modeling with comparison to a wide range of experimental data relating metabolism to neurotransmission strongly supports two concepts: (i) glycogenolysis in astrocytes spares blood‐borne glucose for activated neurons, and (ii) the increase in cerebral blood flow in excess of oxygen consumption removes protons produced by glycolytic metabolism to maintain tissue pH, pO2, and pCO2 homeostasis. Several studies have identified processes and situations that involve neuronal aerobic glycolysis, and a better understanding of the roles of glycolysis in neuron‐astrocyte interactions and functional metabolism in the normal and diseased brain is required. image
- Open Access
- 6 May 2025
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 22 (1) , 1-26
A budget for brain metabolic water production by glucose catabolism during rest, rises in activity and sleep
Maintaining brain fluid homeostasis is of critical importance for creating a stable environment conducive to optimal neuronal functioning, nutrient distribution, and waste product removal. In this study, we employed previously published data on brain oxygen and glucose consumption in awake rodents or humans to quantify the metabolic water production associated with distinct pathways of glucose metabolism. It is predicted that neuronal mitochondria are the primary source of metabolic water at rest, resulting in a continuous efflux into the cytosol, interstitial fluid, and cerebrospinal fluid. Net metabolic water production is predicted to be reduced by increases in activity due to a shift in metabolism from glucose oxidation to include glycolysis in neurons and ATP hydrolysis by the major cation pumps, which involves water consumption (ATP + H2O → ADP + Pi). In comparison, glycogenolysis, which occurs concurrently with the activation of astrocytes, potentially represents a major but previously unidentified contributor to metabolic water. Metabolic water production is dependent on the state of the brain, with a reduction of 30–40% occurring during deep sleep. Our estimates indicate that metabolic water functions as a conduit for interstitial fluid production within the brain, enabling flexible and efficient distribution of fluid that flows seamlessly from the parenchyma to the subarachnoid space and lymphatic vessels to facilitate the removal of brain waste, independent of the glymphatic system.
- 6 May 2025
- Published by Springer Nature in Fluids and Barriers of the CNS
- Vol. 22 (1) , 1-26
Open AccessA budget for brain metabolic water production by glucose catabolism during rest, rises in activity and sleep
Maintaining brain fluid homeostasis is of critical importance for creating a stable environment conducive to optimal neuronal functioning, nutrient distribution, and waste product removal. In this study, we employed previously published data on brain oxygen and glucose consumption in awake rodents or humans to quantify the metabolic water production associated with distinct pathways of glucose metabolism. It is predicted that neuronal mitochondria are the primary source of metabolic water at rest, resulting in a continuous efflux into the cytosol, interstitial fluid, and cerebrospinal fluid. Net metabolic water production is predicted to be reduced by increases in activity due to a shift in metabolism from glucose oxidation to include glycolysis in neurons and ATP hydrolysis by the major cation pumps, which involves water consumption (ATP + H2O → ADP + Pi). In comparison, glycogenolysis, which occurs concurrently with the activation of astrocytes, potentially represents a major but previously unidentified contributor to metabolic water. Metabolic water production is dependent on the state of the brain, with a reduction of 30–40% occurring during deep sleep. Our estimates indicate that metabolic water functions as a conduit for interstitial fluid production within the brain, enabling flexible and efficient distribution of fluid that flows seamlessly from the parenchyma to the subarachnoid space and lymphatic vessels to facilitate the removal of brain waste, independent of the glymphatic system.
- Open Access
- 21 June 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 168 (5) , 632-662
Neurovascular coupling is optimized to compensate for the increase in proton production from nonoxidative glycolysis and glycogenolysis during brain activation and maintain homeostasis of pH, pCO2, and pO2
During transient brain activation cerebral blood flow (CBF) increases substantially more than cerebral metabolic rate of oxygen consumption (CMRO2) resulting in blood hyperoxygenation, the basis of BOLD‐fMRI contrast. Explanations for the high CBF versus CMRO2 slope, termed neurovascular coupling (NVC) constant, focused on maintenance of tissue oxygenation to support mitochondrial ATP production. However, paradoxically the brain has a 3‐fold lower oxygen extraction fraction (OEF) than other organs with high energy requirements, like heart and muscle during exercise. Here, we hypothesize that the NVC constant and the capillary oxygen mass transfer coefficient (which in combination determine OEF) are co‐regulated during activation to maintain simultaneous homeostasis of pH and partial pressure of CO2 and O2 (pCO2 and pO2). To test our hypothesis, we developed an arteriovenous flux balance model for calculating blood and brain pH, pCO2, and pO2 as a function of baseline OEF (OEF0), CBF, CMRO2, and proton production by nonoxidative metabolism coupled to ATP hydrolysis. Our model was validated against published brain arteriovenous difference studies and then used to calculate pH, pCO2, and pO2 in activated human cortex from published calibrated fMRI and PET measurements. In agreement with our hypothesis, calculated pH, pCO2, and pO2 remained close to constant independently of CMRO2 in correspondence to experimental measurements of NVC and OEF0. We also found that the optimum values of the NVC constant and OEF0 that ensure simultaneous homeostasis of pH, pCO2, and pO2 were remarkably similar to their experimental values. Thus, the high NVC constant is overall determined by proton removal by CBF due to increases in nonoxidative glycolysis and glycogenolysis. These findings resolve the paradox of the brain's high CBF yet low OEF during activation, and may contribute to explaining the vulnerability of brain function to reductions in blood flow and capillary density with aging and neurovascular disease. image
- 21 June 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 168 (5) , 632-662
Open AccessNeurovascular coupling is optimized to compensate for the increase in proton production from nonoxidative glycolysis and glycogenolysis during brain activation and maintain homeostasis of pH, pCO2, and pO2
During transient brain activation cerebral blood flow (CBF) increases substantially more than cerebral metabolic rate of oxygen consumption (CMRO2) resulting in blood hyperoxygenation, the basis of BOLD‐fMRI contrast. Explanations for the high CBF versus CMRO2 slope, termed neurovascular coupling (NVC) constant, focused on maintenance of tissue oxygenation to support mitochondrial ATP production. However, paradoxically the brain has a 3‐fold lower oxygen extraction fraction (OEF) than other organs with high energy requirements, like heart and muscle during exercise. Here, we hypothesize that the NVC constant and the capillary oxygen mass transfer coefficient (which in combination determine OEF) are co‐regulated during activation to maintain simultaneous homeostasis of pH and partial pressure of CO2 and O2 (pCO2 and pO2). To test our hypothesis, we developed an arteriovenous flux balance model for calculating blood and brain pH, pCO2, and pO2 as a function of baseline OEF (OEF0), CBF, CMRO2, and proton production by nonoxidative metabolism coupled to ATP hydrolysis. Our model was validated against published brain arteriovenous difference studies and then used to calculate pH, pCO2, and pO2 in activated human cortex from published calibrated fMRI and PET measurements. In agreement with our hypothesis, calculated pH, pCO2, and pO2 remained close to constant independently of CMRO2 in correspondence to experimental measurements of NVC and OEF0. We also found that the optimum values of the NVC constant and OEF0 that ensure simultaneous homeostasis of pH, pCO2, and pO2 were remarkably similar to their experimental values. Thus, the high NVC constant is overall determined by proton removal by CBF due to increases in nonoxidative glycolysis and glycogenolysis. These findings resolve the paradox of the brain's high CBF yet low OEF during activation, and may contribute to explaining the vulnerability of brain function to reductions in blood flow and capillary density with aging and neurovascular disease. image
- 13 April 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 168 (5) , 461-495
A tribute to Leif Hertz: The historical context of his pioneering studies of the roles of astrocytes in brain energy metabolism, neurotransmission, cognitive functions, and pharmacology identifies important, unresolved topics for future studies
Leif Hertz, M.D., D.Sc. (honōris causā) (1930–2018), was one of the original and noteworthy participants in the International Conference on Brain Energy Metabolism (ICBEM) series since its inception in 1993. The biennial ICBEM conferences are organized by neuroscientists interested in energetics and metabolism underlying neural functions; they have had a high impact on conceptual and experimental advances in these fields and on promoting collaborative interactions among neuroscientists. Leif made major contributions to ICBEM discussions and understanding of metabolic and signaling characteristics of astrocytes and their roles in brain function. His studies ranged from uptake of K+ from extracellular fluid and its stimulation of astrocytic respiration, identification, and regulation of enzymes specifically or preferentially expressed in astrocytes in the glutamate–glutamine cycle of excitatory neurotransmission, a requirement for astrocytic glycogenolysis for fueling K+ uptake, involvement of glycogen in memory consolidation in the chick, and pharmacology of astrocytes. This tribute to Leif Hertz highlights his major discoveries, the high impact of his work on astrocyte–neuron interactions, and his unparalleled influence on understanding the cellular basis of brain energy metabolism. His work over six decades has helped integrate the roles of astrocytes into neurotransmission where oxidative and glycogenolytic metabolism during neurotransmitter glutamate turnover are key aspects of astrocytic energetics. Leif recognized that brain astrocytic metabolism is greatly underestimated unless the volume fraction of astrocytes is taken into account. Adjustment for pathway rates expressed per gram tissue for volume fraction indicates that astrocytes have much higher oxidative rates than neurons and astrocytic glycogen concentrations and glycogenolytic rates during sensory stimulation in vivo are similar to those in resting and exercising muscle, respectively. These novel insights are typical of Leif's astute contributions to the energy metabolism field, and his publications have identified unresolved topics that provide the neuroscience community with challenges and opportunities for future research. image
- 13 April 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 168 (5) , 461-495
A tribute to Leif Hertz: The historical context of his pioneering studies of the roles of astrocytes in brain energy metabolism, neurotransmission, cognitive functions, and pharmacology identifies important, unresolved topics for future studies
Leif Hertz, M.D., D.Sc. (honōris causā) (1930–2018), was one of the original and noteworthy participants in the International Conference on Brain Energy Metabolism (ICBEM) series since its inception in 1993. The biennial ICBEM conferences are organized by neuroscientists interested in energetics and metabolism underlying neural functions; they have had a high impact on conceptual and experimental advances in these fields and on promoting collaborative interactions among neuroscientists. Leif made major contributions to ICBEM discussions and understanding of metabolic and signaling characteristics of astrocytes and their roles in brain function. His studies ranged from uptake of K+ from extracellular fluid and its stimulation of astrocytic respiration, identification, and regulation of enzymes specifically or preferentially expressed in astrocytes in the glutamate–glutamine cycle of excitatory neurotransmission, a requirement for astrocytic glycogenolysis for fueling K+ uptake, involvement of glycogen in memory consolidation in the chick, and pharmacology of astrocytes. This tribute to Leif Hertz highlights his major discoveries, the high impact of his work on astrocyte–neuron interactions, and his unparalleled influence on understanding the cellular basis of brain energy metabolism. His work over six decades has helped integrate the roles of astrocytes into neurotransmission where oxidative and glycogenolytic metabolism during neurotransmitter glutamate turnover are key aspects of astrocytic energetics. Leif recognized that brain astrocytic metabolism is greatly underestimated unless the volume fraction of astrocytes is taken into account. Adjustment for pathway rates expressed per gram tissue for volume fraction indicates that astrocytes have much higher oxidative rates than neurons and astrocytic glycogen concentrations and glycogenolytic rates during sensory stimulation in vivo are similar to those in resting and exercising muscle, respectively. These novel insights are typical of Leif's astute contributions to the energy metabolism field, and his publications have identified unresolved topics that provide the neuroscience community with challenges and opportunities for future research. image
- 27 March 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 168 (5) , 506-532
In vivo calibration of genetically encoded metabolite biosensors must account for metabolite metabolism during calibration and cellular volume
Isotopic assays of brain glucose utilization rates have been used for more than four decades to establish relationships between energetics, functional activity, and neurotransmitter cycling. Limitations of these methods include the relatively long time (1–60 min) for the determination of labeled metabolite levels and the lack of cellular resolution. Identification and quantification of fuels for neurons and astrocytes that support activation and higher brain functions are a major, unresolved issues. Glycolysis is preferentially up‐regulated during activation even though oxygen level and supply are adequate, causing lactate concentrations to quickly rise during alerting, sensory processing, cognitive tasks, and memory consolidation. However, the fate of lactate (rapid release from brain or cell–cell shuttling coupled with local oxidation) is long disputed. Genetically encoded biosensors can determine intracellular metabolite concentrations and report real‐time lactate level responses to sensory, behavioral, and biochemical challenges at the cellular level. Kinetics and time courses of cellular lactate concentration changes are informative, but accurate biosensor calibration is required for quantitative comparisons of lactate levels in astrocytes and neurons. An in vivo calibration procedure for the Laconic lactate biosensor involves intracellular lactate depletion by intravenous pyruvate‐mediated trans‐acceleration of lactate efflux followed by sensor saturation by intravenous infusion of high doses of lactate plus ammonium chloride. In the present paper, the validity of this procedure is questioned because rapid lactate–pyruvate interconversion in blood, preferential neuronal oxidation of both monocarboxylates, on‐going glycolytic metabolism, and cellular volumes were not taken into account. Calibration pitfalls for the Laconic lactate biosensor also apply to other metabolite biosensors that are standardized in vivo by infusion of substrates that can be metabolized in peripheral tissues. We discuss how technical shortcomings negate the conclusion that Laconic sensor calibrations support the existence of an in vivo astrocyte–neuron lactate concentration gradient linked to lactate shuttling from astrocytes to neurons to fuel neuronal activity. image
- 27 March 2023
- Published by Wiley in Journal of Neurochemistry
- Vol. 168 (5) , 506-532
In vivo calibration of genetically encoded metabolite biosensors must account for metabolite metabolism during calibration and cellular volume
Isotopic assays of brain glucose utilization rates have been used for more than four decades to establish relationships between energetics, functional activity, and neurotransmitter cycling. Limitations of these methods include the relatively long time (1–60 min) for the determination of labeled metabolite levels and the lack of cellular resolution. Identification and quantification of fuels for neurons and astrocytes that support activation and higher brain functions are a major, unresolved issues. Glycolysis is preferentially up‐regulated during activation even though oxygen level and supply are adequate, causing lactate concentrations to quickly rise during alerting, sensory processing, cognitive tasks, and memory consolidation. However, the fate of lactate (rapid release from brain or cell–cell shuttling coupled with local oxidation) is long disputed. Genetically encoded biosensors can determine intracellular metabolite concentrations and report real‐time lactate level responses to sensory, behavioral, and biochemical challenges at the cellular level. Kinetics and time courses of cellular lactate concentration changes are informative, but accurate biosensor calibration is required for quantitative comparisons of lactate levels in astrocytes and neurons. An in vivo calibration procedure for the Laconic lactate biosensor involves intracellular lactate depletion by intravenous pyruvate‐mediated trans‐acceleration of lactate efflux followed by sensor saturation by intravenous infusion of high doses of lactate plus ammonium chloride. In the present paper, the validity of this procedure is questioned because rapid lactate–pyruvate interconversion in blood, preferential neuronal oxidation of both monocarboxylates, on‐going glycolytic metabolism, and cellular volumes were not taken into account. Calibration pitfalls for the Laconic lactate biosensor also apply to other metabolite biosensors that are standardized in vivo by infusion of substrates that can be metabolized in peripheral tissues. We discuss how technical shortcomings negate the conclusion that Laconic sensor calibrations support the existence of an in vivo astrocyte–neuron lactate concentration gradient linked to lactate shuttling from astrocytes to neurons to fuel neuronal activity. image